Acetyl Gastric Inhibitory Peptide (human) (TFA)

Acetyl Gastric Inhibitory Peptide (human) (TFA)

Cat. No.: DIA-0243211

Size: 10 mg Size: 25 mg Size: 50 mg Size: 100 mg Size: Customer Size
Product Information
Synonyms Human N-acetyl GIP TFA
Formula C228H340N60O67S.C2HF3O2
Molecular Weight 5139.62
Target Insulin Receptor
Product Description Acetyl Gastric Inhibitory Peptide (human) TFA is a fatty acid derivatized analog of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties. Acetyl Gastric Inhibitory Peptide (human) TFA can be used for research of diabetes, insulin resistance and obesity.
Format & Storage
Format Solid
Color White to off-white
Purity 99.70%
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solubility Overview Soluble in water
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top